matched by medicine name — name-based until identifier coding refines it. Full protocol history →
As of 05 Nov 2026 18:21 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2021/023 (29 Apr 2021): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Estradot® 75micrograms/24 hours patchesaffected product · inferred from phrasing | Out of stock, as stated | w/c 31 May 2021precision: a stated week · window end 06 Jun 2021, derived from “w/c 31 May 2021” | notice of 29 Apr 2021 |
| Evorel® 75 patches and Estraderm MX 75® patchesnamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 29 Apr 2021 |
Protocol in force
matched by medicine name — name-based until identifier coding refines it. Full protocol history →
matched by medicine name — name-based until identifier coding refines it. Full protocol history →
matched by medicine name — name-based until identifier coding refines it. Full protocol history →
Named in the source as remaining available
- Evorel® 75 patches and Estraderm MX 75® patches — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Estradot
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 29 Apr 2021. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 29 Apr 2021 | Medicine Supply Notification: Estradot (estradiol hemihydrate) 75micrograms/24 hours patches | Supply notification | Tier 2 | MSN/2021/023 |
Also recorded under
Bracketed names seen in this medicine's notice titles: estradiol hemihydrate. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2025)14 Estradiol (Estradot®) 25 micrograms/24 hours, 37.5 micrograms/24 hours, 50 · issued 11 Apr 2025 · valid until various resupply dates – see below, as stated · matched by name PDF ↗
- MSAN(2024)69 Estradiol (Estradot®) 50micrograms/24 hours, 75micrograms/24 hours, and · issued 27 Dec 2024 · valid until various resupply dates – see below, as stated · matched by name PDF ↗
- MSAN(2023)17 Estradiol (Estradot®) 25micrograms/24 hours, 37.5micrograms/24 hours and · issued 29 Aug 2023 · valid until late September 2023, as stated · matched by name PDF ↗